Home
Organic reaction
Organic synthesis
Synthetic protocols
Organic and Medicinal Chemistry News
Pharmaceuticals Patents News
Universities and Institutes Patents News
Contact
Medicinal chemistry
Drug design
Drug discovery
Drug discovery hit to lead
Druglikeness
Biological activity
Biological target
High-throughput screening
Lead compound
Lipinski's Rule of Five
Medicinal chemistry
Molecular design software
Pharmacophore
Quantitative structure-activity relationship
Pharmacology
Peptidomimetic
Protein
ADME
ADME
Bioavailability
Biopharmaceutics Classification System
Caco-2
Chemical property
Distribution
Drug metabolism
Excretion
Partition coefficient
Pharmacodynamics
Polar surface area
Biological target
Agonist
Allosteric regulation
Biological target
Channel blocker
Enzyme
Enzyme activator
Enzyme inhibitor
G protein-coupled receptor
Inverse agonist
Ligand-gated ion channe
NMDA receptor antagonist
Noncovalent bonding
Nuclear receptor
Protein kinase
Receptor antagonist
Voltage-gated ion channel
Example of drug and therapeutic target
5-HT3 antagonist
Benzodiazepine
Cannabinoid receptor antagonist
Development of dipeptidyl peptidase-4 inhibitors
Discovery and development of CCR5 receptor antagonists
Discovery and development of TRPV1 antagonists
Discovery and development of angiotensin receptor blockers
Discovery and development of cyclooxygenase 2 inhibitors
Glycine receptor
Kainate receptor
NK1 receptor antagonist
Nicotinic agonist
Nicotinic antagonist
P2X purinoreceptor
Triptans: Drug Discovery and Development
Site Search
Newsletter
Enter your email address to get our newsletter.
Close